These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 38522311)
1. Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy. Han L; Xiang X; Fu Y; Wei S; Zhang C; Li L; Liu Y; Lv H; Shan B; Zhao L Phytomedicine; 2024 Jun; 128():155539. PubMed ID: 38522311 [TBL] [Abstract][Full Text] [Related]
2. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756 [TBL] [Abstract][Full Text] [Related]
3. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy. Han L; Dai S; Li Z; Zhang C; Wei S; Zhao R; Zhang H; Zhao L; Shan B J Exp Clin Cancer Res; 2019 Dec; 38(1):501. PubMed ID: 31864387 [TBL] [Abstract][Full Text] [Related]
4. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762. Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885 [TBL] [Abstract][Full Text] [Related]
5. Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway. Yang Y; Li S; Shi W; Jin G; Guo D; Li A; Wang B; Lu B; Feng S Int Immunopharmacol; 2024 Dec; 142(Pt B):113247. PubMed ID: 39321706 [TBL] [Abstract][Full Text] [Related]
6. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma. Wang J; Zhang Z; Che Y; Yuan Z; Lu Z; Li Y; Wan J; Sun H; Chen Z; Pu J; He J Cancer Chemother Pharmacol; 2018 Mar; 81(3):469-481. PubMed ID: 29308536 [TBL] [Abstract][Full Text] [Related]
7. α-Hederin Induces Apoptosis of Esophageal Squamous Cell Carcinoma via an Oxidative and Mitochondrial-Dependent Pathway. Wang J; Wu D; Zhang J; Liu H; Wu J; Dong W Dig Dis Sci; 2019 Dec; 64(12):3528-3538. PubMed ID: 31273592 [TBL] [Abstract][Full Text] [Related]
8. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress. Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517 [TBL] [Abstract][Full Text] [Related]
9. Deoxypodophyllotoxin, a Lignan from Kwak AW; Lee MH; Yoon G; Cho SS; Choi JS; Chae JI; Shim JH Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961992 [TBL] [Abstract][Full Text] [Related]
10. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma. Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264 [TBL] [Abstract][Full Text] [Related]
11. Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels. Dong G; Chen Q; Jiang F; Yu D; Mao Q; Xia W; Shi R; Wang J; Xu L Oncotarget; 2016 Oct; 7(42):68170-68178. PubMed ID: 27626688 [TBL] [Abstract][Full Text] [Related]
12. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma. Chu J; Niu X; Chang J; Shao M; Peng L; Xi Y; Lin A; Wang C; Cui Q; Luo Y; Fan W; Chen Y; Sun Y; Guo W; Tan W; Lin D; Wu C Theranostics; 2020; 10(8):3488-3502. PubMed ID: 32206103 [No Abstract] [Full Text] [Related]
13. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice. Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302 [TBL] [Abstract][Full Text] [Related]
14. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells. Tu Y; Tan F; Zhou J; Pan J Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107 [TBL] [Abstract][Full Text] [Related]
15. MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells. Liu T; Guan F; Wang Y; Zhang Z; Li Y; Cui Y; Li Z; Liu H; Zhang Y; Wang Y; Ma S Toxicol Appl Pharmacol; 2020 May; 395():114971. PubMed ID: 32217144 [TBL] [Abstract][Full Text] [Related]
16. Xerophilusin B induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma cells and does not cause toxicity in nude mice. Yao R; Chen Z; Zhou C; Luo M; Shi X; Li J; Gao Y; Zhou F; Pu J; Sun H; He J J Nat Prod; 2015 Jan; 78(1):10-6. PubMed ID: 25555195 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206 [TBL] [Abstract][Full Text] [Related]
18. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. Shen Z; Xu L; Li J; Zhang N Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955 [TBL] [Abstract][Full Text] [Related]
19. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171 [TBL] [Abstract][Full Text] [Related]
20. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect. Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]